Allergan USA, Inc. v. Sun Pharm. Indus. Ltd.
JD Supra Law
FEBRUARY 14, 2023
Case Name: Allergan USA, Inc. v. Sun Pharm. Indus. Ltd., No. CV 19-1727-RGA, 2022 WL 16921800 (D. Del. Nov. 14, 2022) (Andrews, J.) Drug Product and Patents-in-Suit: Viberzi® (eluxadoline); U.S. Patents Nos. 9,675,587 (“the ’587 patent”), 10,188,632 (“the ’632 patent”), 11,007,179 (“the ’179 patent”), 11,090,291 (“the ’291 patent”), 11,160,792 (“the ’792 patent”), 11,229,627 (“the ’627 patent”), and 11,311,516 (“the ’516 patent”).
Let's personalize your content